C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) A61K 39/395 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2638851
The present invention relates to human thymic stromal lymphopoietin (hTSLP) antibodies and especially those which neutralize hTSLP activity. It further relates to methods for using anti- hTSLP antibody molecules in diagnosis or treatment of hTSLP related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
La présente invention concerne des anticorps de la lymphopoïétine stromale thymique humaine (hTSLP), notamment ceux qui neutralisent l'activité de hTSLP. L'invention concerne également des procédés d'utilisation des molécules d'anticorps anti-hTSLP pour le diagnostic ou le traitement de troubles liés à hTSLP, tels que l'asthme, la dermatite atopique, la rhinite allergique, la fibrose, l'affection abdominale inflammatoire et le lymphome de Hodgkin.
Bardroff Michael
Edwards Matthew
Ratsch Olaf
Tur Mehmet
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Thymic stromal lymphopoietin (tslp) antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thymic stromal lymphopoietin (tslp) antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymic stromal lymphopoietin (tslp) antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1770403